動物用血液分析装置市場：製品タイプ、用途、動物タイプ、地域別、2024年～2031年

動物用血液分析装置市場の評価、2024年～2031年

コンパニオンアニマルの飼育増加と人獣共通感染症の流行増加は、診断や治療を含む獣医学サービスの需要拡大の主な要因です。先進諸国では、動物の健康に対する支出の増加とペット保険の普及がこの動向をさらに後押ししています。したがって、コンパニオンアニマルの採用が増加しているため、市場規模は2024年に8億6,925万米ドルを突破し、2031年までに14億6,035万米ドルの評価額に達するまで急成長しました。

ペットの人口が増加し、より多くの資源が動物のヘルスケアに割り当てられるにつれて、迅速かつ正確な診断能力で知られる獣医血液学分析装置の必要性が高まっています。これらの高度なツールは、赤血球、白血球、血小板などの血液成分に関する詳細な情報を提供し、動物のさまざまな血液疾患の診断と管理に不可欠です。したがって、ペット人口の増加により、市場は2024年から2031年までCAGR 6.70%で成長します。

動物用血液分析装置市場定義/概要

動物用血液分析装置は、動物病院における全血球算定（CBC）の実施に不可欠な高度医療機器です。これらの高度な機器は、血液サンプルの分析プロセスを自動化し、分光光度法、フローサイトメトリー、インピーダンスカウンティングなどの最先端技術を採用することで、さまざまな重要な診断情報を提供します。これらの分析装置は、赤血球（RBC）、白血球（WBC）、血小板を含む様々な血液成分に関する定性的および定量的データを提供することにより、正確で信頼性の高い結果をもたらします。

これらの血液学分析装置が提供する詳細な分析は、基本的な計数にとどまらず、ヘモグロビンレベルや単球、リンパ球、好塩基球などの特定の細胞タイプの濃度に関する包括的な洞察を含みます。この詳細な情報は、獣医師が貧血、感染症、免疫系疾患、がんなど、動物に影響を及ぼす様々な状態を診断・管理する上で極めて重要です。例えば、赤血球やヘモグロビンが減少していれば、疲労や衰弱の症状を説明できるかもしれません。

全血球計算の結果は、獣医師が根本的な健康問題を特定し、適切な治療戦略を導くための重要な指標となります。動物用血液分析装置には、ルーチン検査用の卓上型や、臨床現場ですぐに結果を得るためのポイント・オブ・ケア型など、さまざまな形式があります。これらの分析装置は診断プロセスを合理化し、獣医療の正確性と効率を高め、最終的にはタイムリーで十分な情報に基づいた意思決定により患者の転帰を改善します。

人獣共通感染症の発生率の増加とヒトと動物の相互作用の増加は、どのように動物用血液分析装置市場の成長を急増させるのか？

気象パターンの変化や気候変動に影響された人獣共通感染症の発生率の増加は、動物の健康に対する認識と関心を高めています。異常気象や生息環境の変化により、人と動物の相互作用の可能性が高まり、人獣共通感染症のトランスミッションのリスクが高まっています。例えば、COVID-19のパンデミックは、動物からヒトへの感染が報告されており、動物衛生対策の改善の重要性が浮き彫りになっています。このため、予防接種、薬剤、診断ツールの進歩など、動物ヘルスケア調査への取り組みが強化されています。

また、人獣共通感染症が個人と公衆衛生の双方に与える影響の大きさから、動物衛生に対する政府の投資も急増しています。動物医療における研究開発資金の増加は、動物用血液分析装置市場の今後の成長を促進すると予想されます。この投資は、より効果的な医薬品、ワクチン、診断ツールの開発を支援するだけでなく、業界内の技術革新を刺激します。

民間企業は製品ラインナップを充実させ、研究開発への投資を増やすことで、こうした動向に対応しています。ペットの飼育数が増え続け、可処分所得が増加するにつれて、動物用医薬品とサービスの市場は拡大し、企業にとって魅力的な機会が生まれます。ペットの個体数の増加、人獣共通感染症に対する意識の高まり、動物衛生研究への投資の増加などが相まって、動物用血液分析装置市場の将来は有望です。

人獣共通感染症の増加はどのように動物用血液分析装置市場の成長を妨げるか？

動物衛生管理と規制の枠組みが動物用血液分析装置市場の成長を阻害しています。現代社会では、ペット飼育の増加、生息地の減少、人間の侵入などにより、人間と動物との相互作用が増加し、人畜共通感染症のリスクが高まっています。一次蛋白源として食肉消費に依存し続けることは、動物からヒトへの疾病伝播の可能性を高めるため、このリスクをさらに増幅させています。

人獣共通感染症が社会的、経済的、環境的福利に与える影響を軽減するため、動物の健康に関する政府の規制や監視ガイドラインが厳格に実施されています。しかし、このような厳しい規制は市場の成長に制約を与えることもあります。複雑な規制基準への準拠と厳格な承認の必要性により、新しい動物用血液分析装置と関連技術の開発と導入が遅れる可能性があります。

多額の資金を背景とした動物衛生インフラ強化のための最近の政府の取り組みにより、一部の地域では進展が加速しています。しかし、低・中所得国では、こうしたプロジェクトの効果や資金の配分は満足のいくものではありません。例えば、インドで最近発生した牛のしこり皮膚病は、同国の動物医療システムの重大な欠点を浮き彫りにしました。この大発生は、鶏やアヒルの淘汰に関わる過去の事件とともに、人獣共通感染症の開発、モニタリング、検査、追跡、隔離、治療、ワクチン接種のためのインフラの不備を浮き彫りにしています。

こうしたインフラの不備は、多大な経済的損失をもたらし、市場の拡大を妨げています。適切なインフラと予防措置によって人獣共通感染症に効果的に対処・管理できないことが、動物用血液分析装置市場の成長可能性を制限しています。疾病管理のための包括的なシステムの欠如と、効果的な衛生対策を実施・維持する能力の限界が、市場開拓に大きな課題をもたらしています。

目次

第1章 動物用血液分析装置の世界市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 動物用血液分析装置の世界市場展望

• 概要
• 市場力学
• 促進要因
• 抑制要因
• 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 動物用血液分析装置の世界市場：製品別

• 全自動分析装置
• 半自動分析装置

第6章 動物用血液分析装置の世界市場：用途別

• 調査機関
• 獣医診断センター
• 動物病院および診療所
• その他（ポイントオブケア検査、院内検査）

第7章 動物用血液分析装置の世界市場：地域別

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• ドイツ
• 英国
• フランス
• その他欧州
• アジア太平洋
• 中国
• 日本
• インド
• その他アジア太平洋地域
• 世界のその他の地域
• ラテンアメリカ
• 中東・アフリカ

第8章 動物用血液分析装置の世界市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• IDEXX
• VetScan
• Abaxis
• Boule Medical
• Clindiag Systems
• Woodley Equipment
• Sysmex
• Siemens Healthineers
• Diatron MI
• Drew Scientific
• HemoCue
• Heska
• HORIBA Medical
• Mindray Medical International
• Qreserve
• Urit Medical
• Rayto Life and Analytical Sciences

第10章 付録

• 関連レポート

Veterinary Hematology Analyzers Market Valuation - 2024-2031

The increasing adoption of companion animals and the rising prevalence of zoonotic diseases are primary contributors to the expanding demand for veterinary services, including diagnostics and treatment. In developed countries, the growing expenditure on animal health and the rising adoption of pet insurance further support this trend. Thus, the growing adoption of companion animals surged the growth of market size surpassing USD 869.25 Million in 2024 to reach a valuation of USD 1460.35 Million by 2031.

As the pet population grows and more resources are allocated to animal healthcare, the need for veterinary hematology analyzers known for their rapid and precise diagnostic capabilities-has increased. These sophisticated tools provide detailed information on blood components such as red blood cells, white blood cells, and platelets, which are crucial for diagnosing and managing various hematological disorders in animals. Thus, the increasing pet population enables the market to grow at aCAGR of 6.70% from 2024 to 2031.

Veterinary Hematology Analyzers Market: Definition/ Overview

Veterinary hematology analyzers are sophisticated medical devices essential for performing complete blood counts (CBC) in veterinary practices. These advanced instruments automate the process of analyzing blood samples, offering a range of crucial diagnostic information by employing state-of-the-art technologies such as spectrophotometry, flow cytometry, and impedance counting. These analyzers deliver precise and reliable results by providing qualitative and quantitative data on various blood elements-including red blood cells (RBCs), white blood cells (WBCs), and platelets.

The detailed analysis provided by these hematology analyzers extends beyond basic counts to include comprehensive insights into hemoglobin levels and the concentrations of specific cell types such as monocytes, lymphocytes, and basophils. This in-depth information is pivotal for veterinarians as they diagnose and manage various conditions affecting animals, including anemia, infections, immune system disorders, and cancer. For instance, elevated WBC counts might suggest an ongoing immune response to an infection, while reduced RBC or hemoglobin levels could explain symptoms of fatigue or weakness.

The results from a complete blood count act as crucial indicators, helping veterinarians to identify underlying health issues and guide appropriate treatment strategies. Veterinary hematology analyzers come in various formats, including tabletop models for routine lab use and point-of-care devices for immediate results in clinical settings. These analyzers streamline the diagnostic process and enhance the accuracy and efficiency of veterinary care, ultimately improving patient outcomes through timely and informed decision-making.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How does the Increasing Incidence of Zoonotic Diseases and Rising Human-animal Interaction Surge the Growth of the Veterinary Hematology Analyzers Market?

The growing incidence of zoonotic diseases, influenced by changing weather patterns and climate change, has heightened awareness and focus on animal health. Extreme weather conditions and habitat changes have increased the likelihood of human-animal interactions, thereby raising the risk of zoonotic disease transmission. For example, the COVID-19 pandemic, which reportedly spread from animals to humans, underscores the importance of improved animal health measures. This has led to intensified efforts in animal healthcare research, including advancements in vaccinations, drugs, and diagnostic tools.

Government investment in animal health has also surged, driven by the significant impact of zoonotic diseases on both individuals and public health. Increased funding for research and development in animal healthcare is expected to drive future growth in the veterinary hematology analyzers market. This investment not only supports the development of more effective drugs, vaccines, and diagnostic tools but also stimulates innovation within the industry.

Private sector firms are responding to these trends by enhancing their product offerings and increasing their investment in R&D. As pet ownership continues to rise and disposable incomes grow, the market for veterinary products and services expands, creating attractive opportunities for businesses. The combination of rising pet populations, heightened awareness of zoonotic diseases, and increased investment in animal health research ensures a promising future for the veterinary hematology analyzers market.

How Increasing Zoonotic Diseases Hinder the Growth of Veterinary Hematology Analyzers Market?

The animal health management and regulatory frameworks impede the growth of the veterinary hematology analyzers market. In the modern world, the increase in interaction between humans and animals due to rising pet adoption, habitat loss, and human encroachment has heightened the risk of zoonotic diseases. The continued reliance on meat consumption as a primary protein source further amplifies this risk, as it increases the potential for disease transmission from animals to humans.

Government regulations and monitoring guidelines related to animal health are implemented rigorously to mitigate the impact of zoonotic diseases on social, economic, and environmental well-being. However, these stringent regulations can also impose limitations on market growth. Compliance with complex regulatory standards and the need for rigorous approvals can slow down the development and introduction of new veterinary hematology analyzers and related technologies.

Recent government initiatives to strengthen animal health infrastructure, backed by significant funding, have accelerated progress in some regions. However, in low- and middle-income countries, the effectiveness of these projects and the allocation of funds have been less satisfactory. For example, the recent outbreak of lumpy skin disease among cattle in India highlights significant shortcomings in the country's animal healthcare system. This outbreak, along with previous incidents involving the culling of chickens and ducks, underscores the inadequacies in infrastructure for developing, monitoring, testing, tracing, isolating, treating, and vaccinating against zoonotic diseases.

These deficiencies in infrastructure contribute to substantial economic losses and hinder the market's expansion. The inability to effectively address and manage zoonotic diseases through adequate infrastructure and preventative measures restricts the growth potential of the veterinary hematology analyzers market. The lack of comprehensive systems for disease control and the limited capacity to implement and sustain effective health measures pose significant challenges for the market's development.

Category-Wise Acumens

Will Demand for Precision and High-Volume Settings Surge the Growth of Fully Automatic Analyzers Segment?

The fully automatic analyzer segment shows significant growth in the veterinary hematology analyzers market owing to the growing adoption in veterinary practices. These advanced systems are favored for their improved accuracy and precision, high throughput, and ability to handle large sample volumes efficiently. By significantly reducing manual labor and streamlining the diagnostic process, fully automatic analyzers offer a substantial advantage, particularly in high-volume settings.

In veterinary clinics, the choice of analyzer often depends on clinic size and workflow. Smaller clinics frequently opt for table-top analyzers due to their simplicity and cost-effectiveness. These models are well-suited for lower sample volumes and provide a practical solution for routine diagnostics. Conversely, larger clinics and laboratories, which manage higher volumes of samples, prefer fully automatic analyzers for their efficiency and capability to process extensive workloads.

Budget constraints also play a crucial role in the selection of hematology analyzers. Cost considerations can influence whether a clinic or laboratory invests in high-end fully automatic systems or more affordable options. Technological advancements are continuously enhancing the features of fully automatic analyzers, with improvements in functionality and reductions in costs driving their increased adoption.

Moreover, the integration of automation in semi-automatic analyzers bridges the gap between fully automatic and manual systems, offering a middle ground that combines automation with manual flexibility. Advancements in point-of-care testing technologies could also impact the popularity of table-top analyzers by providing rapid, on-site diagnostic capabilities.

The incorporation of artificial intelligence (AI) for data analysis and interpretation is further enhancing the capabilities of all types of hematology analyzers. AI integration helps in refining diagnostic accuracy and streamlining the interpretation of results, thus adding value across various product segments. As these technological advancements continue to evolve, they will likely shape the future dynamics of the veterinary hematology analyzers market.

How does the High Prevalence of Dogs and Cats, and Increasing Pet Ownership Foster the Growth of the Companion Animals Segment?

Companion animals significantly dominate the veterinary hematology analyzers market due to the high prevalence of dogs and cats as companion animals, increasing pet ownership, and growing expenditure on pet healthcare. The dominance of this segment can be attributed to several factors. The sheer number of dogs and cats globally ensures that these animals represent a significant portion of the market, as they constitute the majority of pets receiving veterinary care. The trend of pet humanization where pets are increasingly regarded and treated as family members has led to heightened spending on their healthcare, including diagnostic tests.

This growing awareness about pet health and the rising demand for preventive healthcare are major growth drivers for veterinary hematology analyzers. Pet owners are now more informed about the importance of regular health checks and early disease detection, which fuels the demand for comprehensive diagnostic tools. For instance, certain diseases, such as heartworm in dogs, create specific diagnostic needs that drive the demand for accurate and reliable hematology analyzers tailored to these conditions.

In addition to the strong focus on dogs and cats, there is an emerging growth trend in the equine market, driven by increased attention to horse health and welfare. This shift is expected to boost demand for hematology analyzers designed specifically for equines, addressing their unique diagnostic requirements.

The development of specialized analyzers tailored to different animal types is likely to become a key trend, as it aims to meet the diverse diagnostic needs of various pets. The emphasis on companion animal wellness, driven by the desire for preventive care and early detection of diseases, will continue to propel the demand for hematology analyzers. As pet owners increasingly seek to provide their animals with the best possible care, the market for veterinary hematology analyzers will continue to expand, reflecting the broader trends in pet healthcare and wellness.

Country/Region-wise Acumens

How will Dietary Habits and Need for Effective Animal Health Management in North America Favor the Growth of Veterinary Hematology Analyzers Market?

North America, is dominating the veterinary hematology analyzers market and is anticipated to continue its dominance throughout the forecast period owing to the region's dietary habits and the need for effective animal health management. With a large proportion of the population adhering to non-vegetarian diets, meat consumption is substantial, driving the demand for commercial animal breeding to meet these needs. This high demand necessitates stringent measures to ensure animal health and welfare, which fuels the market for veterinary diagnostics and tools.

The market's expansion is supported by strict government regulations and the presence of numerous organizations dedicated to animal health and welfare. The COVID-19 pandemic has highlighted the critical importance of monitoring zoonotic diseases, underscoring the need for advanced diagnostic tools to prevent outbreaks that could have severe consequences. As zoonotic diseases become more prevalent, fiscal authorities are increasingly compelled to invest in and support industrial measures that enhance animal health and safety.

Technological advancements and access to state-of-the-art technology are also driving the growth of the veterinary hematology analyzers market. Innovations in diagnostics and the development of advanced healthcare solutions are contributing to a more robust infrastructure for animal health. This growth is further bolstered by the rising adoption of pet insurance and the rapidly increasing number of companion animals. As pet ownership continues to rise, there is a greater emphasis on preventive care and early disease detection, driving demand for advanced diagnostic tools.

The combination of these factors dietary habits, regulatory support, technological progress, and increased pet ownership creates a favorable environment for the expansion of the veterinary hematology analyzers market. As the focus on animal health intensifies and technological capabilities advance, the demand for high-quality veterinary diagnostics will continue to grow, reflecting broader trends in animal welfare and healthcare.

How the Increasing Pet Ownership and Need for Veterinary Services Foster the Growth of Veterinary Hematology Analyzers Market in Asia Pacific During the Forecast Period?

Asia Pacific is anticipated to witness the fastest growth in the veterinary hematology analyzers market during the forecast period owing to the surge in pet ownership, especially in urban areas, which has significantly increased the need for veterinary services, including advanced diagnostic tools. As more households embrace pet ownership, the demand for veterinary care has risen, creating a substantial market for hematology analyzers.

The rise in disposable incomes has also contributed to this growth, as economic prosperity allows pet owners to spend more on high-quality pet care, including diagnostic tests. This trend is supported by the expanding veterinary infrastructure, with new clinics and hospitals being established to cater to the growing pet population. These facilities are increasingly equipped with advanced diagnostic equipment to meet the demands of modern veterinary practice.

Government initiatives aimed at improving animal healthcare and disease control are further enhancing market conditions. Supportive policies and funding for animal health initiatives contribute to a favorable environment for the adoption of advanced veterinary technologies. In emerging economies like China and India, significant growth potential exists due to large pet populations and a burgeoning middle class that is increasingly prioritizing pet care.

The preference for fully automated and semi-automatic analyzers is rising, driven by the need for efficiency and accuracy in diagnostic testing. This trend reflects the broader focus on companion animals, with dogs and cats currently dominating the market. However, there is a growing interest in the livestock sector, particularly in countries with substantial livestock populations, where the demand for hematology analyzers is gradually increasing.

In Addition, increasing demand for cost-effective solutions, catering to the needs of smaller veterinary clinics that require affordable yet reliable diagnostic tools. As the market continues to evolve, the combination of these factors rising pet ownership, increased disposable incomes, expanding veterinary infrastructure, supportive government initiatives, and advancements in diagnostic technology will likely drive further growth in the veterinary hematology analyzers market.

Competitive Landscape

The veterinary hematology analyzer market is characterized by a dynamic interplay of established players and emerging companies. While the overall market size is relatively smaller compared to human healthcare, the increasing adoption of companion animals and the growing focus on preventive healthcare has led to significant market growth.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the veterinary hematology analyzers market include:

• IDEXX
• VetScan
• Abaxis, Boule Medical
• Clindiag Systems
• Woodley Equipment
• Sysmex, Siemens Healthineers
• Diatron MI, Drew Scientific
• HemoCue
• Heska
• HORIBA Medical
• Mindray Medical International
• Qreserve
• Urit Medical
• Rayto Life and Analytical Sciences

Latest Developments:

• In August 2022, IDEXX Laboratories, Inc. announced the launch of the ProCyte One Hematology Analyzer to improve workflow efficiency and accuracy at the point of care, resulting in product enhancements.
• In October 2022, Zoetis, Inc. announced the launch of their VETSCAN hematological analyzers, allowing for quick and uncomplicated diagnostics at the point of care. This product introduction expanded Zoetis' product line for veterinary diagnostics.

TABLE OF CONTENTS

1. Introduction of Global Veterinary Hematology Analyzers Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Veterinary Hematology Analyzers Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Veterinary Hematology Analyzers Market, By Product

• Fully Automatic Analyzers
• Semi-Automatic Analyzers

6. Global Veterinary Hematology Analyzers Market, By Application

• Research Institutes
• Veterinary Diagnostic Centers
• Veterinary Hospitals and Clinics
• Others (Point of care testing, in house testing)

7. Global Veterinary Hematology Analyzers Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Veterinary Hematology Analyzers Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• IDEXX
• Overview
• Financial Performance
• Product Outlook

Key Developments

• VetScan
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Abaxis
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Boule Medical
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Clindiag Systems
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Woodley Equipment
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Sysmex
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Siemens Healthineers
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Diatron MI
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Drew Scientific
• Overview
• Financial Performance
• Product Outlook

Key Developments

• HemoCue
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Heska
• Overview
• Financial Performance
• Product Outlook

Key Developments

• HORIBA Medical
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Mindray Medical International
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Qreserve
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Urit Medical
• Overview
• Financial Performance
• Product Outlook

Key Developments

• Rayto Life and Analytical Sciences
• Overview
• Financial Performance
• Product Outlook

Key Developments

10. Appendix

• Related Reports